Ameritas Investment Partners’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Ameritas Investment Partners’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,309	Closed	-$174K	–	3361
2022 Q1	$174K	Hold	9,309	–	–	0.01%	1259
2021 Q4	$199K	Buy	9,309 +823	+10%	+$16.2K	0.01%	1242
2021 Q3	$157K	Buy	8,486 +1,309	+18%	+$26.4K	0.01%	1393
2021 Q2	$154K	Hold	7,177	–	–	0.01%	1446
2021 Q1	$138K	Buy	+7,177	New	+$126K	0.01%	1457

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ameritas Investment Partners's OCDX Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 9,309 shares — an estimated $174K sold.

Ameritas Investment Partners first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $199K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Ameritas Investment Partners reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 9,309 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $174K.
Ameritas Investment Partners first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Ameritas Investment Partners's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $199K in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.